loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: 01885_FLUKA

    Client Email Product
    Menu

    01885_FLUKA

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 48,532Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 201195 / DOSAGE - INJECTABLE;INJECTION - 20MG/ML (20MG/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DOCETAXEL ANHYDROUS(UNII: 699121PHCA)
    (DOCETAXEL ANHYDROUS - UNII:699121PHCA)     		DOCETAXEL ANHYDROUS20mg in 1 | 20mg in 1

    Inactive Ingredients

    Ingredient Name
    Actavis Pharma, Inc.
    Hikma Pharmaceuticals USA Inc.
    McKesson Packaging Services a business unit of McKesson Corporation
    Northstar RxLLC
    Sagent Pharmaceuticals
    Sanofi-Aventis U.S. LLC
    Teva Parenteral Medicines, Inc.
    Jiangsu Hengrui Pharmaceuticals Co., Ltd.
    ALCOHOL(3K9958V90M) 
    ANHYDROUS CITRIC ACID(XF417D3PSL)  
    polysorbate 80(6OZP39ZG8H) 
    povidone k12(333AG72FWJ)